|
1
|
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.
|
Aliment Pharmacol Ther
|
2011
|
1.21
|
|
2
|
Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
|
N Engl J Med
|
1997
|
1.07
|
|
3
|
Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment.
|
Pharmacotherapy
|
1988
|
0.99
|
|
4
|
Treatment of suspected postcholecystectomy diarrhea with psyllium hydrophilic mucilloid.
|
Clin Pharm
|
1990
|
0.94
|
|
5
|
Development of a questionnaire for detecting potential adverse drug reactions.
|
Ann Pharmacother
|
1992
|
0.93
|
|
6
|
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
|
J Rheumatol
|
1999
|
0.93
|
|
7
|
Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
|
Thyroid
|
1993
|
0.87
|
|
8
|
Repaglinide-induced factitious hypoglycemia.
|
J Clin Endocrinol Metab
|
2001
|
0.83
|
|
9
|
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
|
Clin Nephrol
|
1999
|
0.83
|
|
10
|
Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders.
|
Ann Pharmacother
|
2001
|
0.81
|
|
11
|
Use of herbal therapies by adults seen in an ambulatory care research setting: an exploratory survey.
|
J Altern Complement Med
|
2000
|
0.80
|
|
12
|
Levothyroxine replacement therapy in central hypothyroidism: a practice report.
|
Pharmacotherapy
|
1999
|
0.79
|
|
13
|
Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis.
|
Pharmacotherapy
|
2001
|
0.79
|
|
14
|
The interdisciplinary team's approach to lupus nephritis.
|
Lupus
|
1998
|
0.78
|
|
15
|
The pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid arthritis.
|
Pharmacotherapy
|
1999
|
0.78
|
|
16
|
Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis.
|
Medicine (Baltimore)
|
2000
|
0.78
|
|
17
|
Patient-interactive computer system for obtaining medication histories.
|
Am J Hosp Pharm
|
1993
|
0.77
|
|
18
|
Evaluation of creatinine clearance estimation in an elderly male population.
|
Pharmacotherapy
|
1988
|
0.77
|
|
19
|
Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study.
|
Pharmacotherapy
|
1989
|
0.77
|
|
20
|
Effects of restricting levothyroxine dosage strength availability.
|
Pharmacotherapy
|
1997
|
0.77
|
|
21
|
Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis.
|
Ann Pharmacother
|
1996
|
0.77
|
|
22
|
Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: a review of the literature.
|
Pharmacotherapy
|
2001
|
0.76
|
|
23
|
Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.
|
J Endocrinol Invest
|
2000
|
0.75
|
|
24
|
Therapeutic drug monitoring in the long-term care facility.
|
J Pharm Technol
|
1989
|
0.75
|
|
25
|
Evaluation of two over-the-counter natural thyroid hormone preparations in human volunteers.
|
Ann Pharmacother
|
1992
|
0.75
|
|
26
|
Automated therapeutic drug monitoring in an ambulatory care endocrine clinic.
|
Ann Pharmacother
|
1992
|
0.75
|
|
27
|
Pharmacogeriatrics.
|
Pharmacotherapy
|
1986
|
0.75
|
|
28
|
Continuous nasogastric morphine infusion.
|
Drug Intell Clin Pharm
|
1987
|
0.75
|
|
29
|
Therapeutic potential of two over-the-counter thyroid hormone preparations.
|
DICP
|
1990
|
0.75
|